Recent Advances of Bispecific Antibodies in Solid Tumors

Journal of Hematology and Oncology - United Kingdom
doi 10.1186/s13045-017-0522-z
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Advances in Cancer Immunotherapy in Solid Tumors

Cancers
Cancer ResearchOncology
2016English

Chemically Modified Bispecific Antibodies

Science-Business eXchange
2012English

Bispecific Antibodies in the Treatment of Hematologic Malignancies

Clinical Pharmacology and Therapeutics
Pharmacology
2019English

Monoclonal Antibodies and Fc Fragments for Treating Solid Tumors

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2012English

An Anti–glypican 3/Cd3 Bispecific T Cell–redirecting Antibody for Treatment of Solid Tumors

Science Translational Medicine
Medicine
2017English

Recent Advances in Targeted Therapy of Colorectal Cancer: Impacts of Monoclonal Antibodies Nanoconjugates

BioImpacts
BiochemistryMedicineGeneticsMolecular BiologyPharmaceutical Science
2019English

A Novel Carcinoembryonic Antigen T-Cell Bispecific Antibody (CEA TCB) for the Treatment of Solid Tumors

Clinical Cancer Research
Cancer ResearchOncology
2016English

Monoclonal and Bispecific Antibodies as Novel Therapeutics

Archivum Immunologiae et Therapiae Experimentalis
MedicineAllergyImmunology
2006English

Expanding the Boundaries of Biotherapeutics With Bispecific Antibodies

BioDrugs
MedicineBiotechnologyPharmacology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy